[{"NetIncomeLoss_2_Q2_USD":1440023000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":103578000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":31151000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":95397000.0,"EquitySecuritiesFvNiCost_0_Q2_USD":67054000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-14121000.0,"InterestPaidNet_2_Q2_USD":27347000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":187300000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":54167000.0,"EquitySecuritiesFvNiUnrealizedGain_2_Q2_USD":152273000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":1545407000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":68400000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":619437000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":213058000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_2_Q2_USD":-300000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1_Q2_USD":4700000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":3080000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":139247000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":86038000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":137498000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":347017000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":184520000.0,"ContractWithCustomerLiability_0_Q2_USD":70700000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q2_USD":-19680000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_2_Q2_USD":-898000.0,"Liabilities_0_Q2_USD":2697125000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":522067000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":374062000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":126577000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-16307000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_0_Q2_USD":121.0,"AssetsCurrent_0_Q2_USD":6694320000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-10538000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-13200000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":191804000.0,"EquitySecuritiesFvNiUnrealizedLoss_2_Q2_USD":0.0,"Cash_0_Q2_USD":2300000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":4831332000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":42281000.0,"AccountsReceivableNetCurrent_0_Q2_USD":791768000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":55235000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":116365000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":263746000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":263403000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":20730000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":65116000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":2714000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":1950000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-3379000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":145395000.0,"EarningsPerShareBasic_1_Q2_USD":3.22,"EarningsPerShareBasic_2_Q2_USD":5.54,"ResearchAndDevelopmentExpense_1_Q2_USD":420928000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-12500000.0,"CommonStockValue_0_Q2_USD":2601000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":232895000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":117189000.0,"OtherAssetsNoncurrent_0_Q2_USD":176564000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":14697000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":809766000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":1427875000.0,"IncreaseDecreaseInInventories_2_Q2_USD":64386000.0,"CostsAndExpenses_1_Q2_USD":806452000.0,"CostsAndExpenses_2_Q2_USD":1601335000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":7943717000.0,"ImpairmentOfInvestments_1_Q2_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":10800000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":9200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-239405000.0,"SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_0_Q2_USD":139.99,"IncreaseDecreaseInOtherDeferredLiability_2_Q2_USD":8963000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":53518000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":34886000.0,"ImpairmentOfInvestments_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":869456000.0,"IncomeTaxesPaidNet_2_Q2_USD":36813000.0,"CommonStockSharesIssued_0_Q2_shares":260124000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":235021000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":139247000.0,"InterestIncomeExpenseNet_1_Q2_USD":-13871000.0,"InterestIncomeExpenseNet_2_Q2_USD":-28007000.0,"Goodwill_0_Q2_USD":1002158000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-27504000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-12148000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":5800000.0,"EarningsPerShareDiluted_2_Q2_USD":5.46,"EarningsPerShareDiluted_1_Q2_USD":3.18,"CommonStockSharesOutstanding_0_Q2_shares":260124000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":164139000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1715019000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-412955000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":29735000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":118121000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1854225000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":30162000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":132781000.0,"NetIncomeLoss_1_Q2_USD":837270000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":728357000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_2_Q2_USD":127874000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":187300000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":7519242000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":37314000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":400000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":4835700000.0,"AccountsPayableCurrent_0_Q2_USD":101451000.0,"LiabilitiesCurrent_0_Q2_USD":1798640000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":2939879000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":259637000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":260013000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_Q2_USD":210375000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":232565000.0,"EquitySecuritiesFvNi_0_Q2_USD":219327000.0,"OtherLiabilitiesCurrent_0_Q2_USD":151782000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":369851000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":28923000.0,"InvestmentIncomeInterestAndDividend_1_Q2_USD":4243000.0,"InvestmentIncomeInterestAndDividend_2_Q2_USD":16819000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q2_USD":1214968000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0_Q2_shares":2623000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":932000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":2126000.0,"ShareBasedCompensation_2_Q2_USD":232895000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":85500000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":35200000.0,"Assets_0_Q2_USD":10216367000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":2974765000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":134889000.0,"IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_2_Q2_shares":20000.0,"IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_1_Q2_shares":8000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1524485000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":117189000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":232895000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":10216367000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_Q2_USD":11977000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":-187000000.0,"PreferredStockValue_0_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":189118000.0,"StockRepurchasedDuringPeriodValue_2_Q2_USD":300026000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_2_Q2_USD":-171000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":300026000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":1482304000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":824770000.0,"OperatingIncomeLoss_1_Q2_USD":718033000.0,"OperatingIncomeLoss_2_Q2_USD":1438257000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3039592000.0,"InventoryNet_0_Q2_USD":219218000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0_Q2_shares":4588000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200731"}]